Bank Of New York Mellon Corp Jaguar Health, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.08 - $809.55 $13,415 - $136 Million	167,697 New	167,697 $15,000
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.71 $259 - $682	-961 Reduced 0.57%	168,788 $50,000
Q1 2022 May 11, 2022	BUY	$0.38 - $1.07 $53,882 - $151,721	141,796 Added 507.27%	169,749 $120,000
Q4 2021 Feb 11, 2022	SELL	$1.03 - $2.48 $1 - $2	-1 Reduced -0.0%	27,953 $29,000
Q3 2021 Nov 12, 2021	BUY	$2.14 - $4.95 $59,821 - $138,372	27,954 New	27,954 $63,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $125M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.